Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pelthos Therapeutics Inc (PTHS)

Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pelthos Therapeutics Inc 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 USA

www.pelthos.com Employees: 11 P: 919-908-2400

Sector:

Medical

Description:

Pelthos Therapeutics is a biopharmaceutical company. Its lead product includes ZELSUVMI(TM) topical gel. Pelthos Therapeutics, formerly known as Channel Therapeutics Corporation, is based in DURHAM, N.C.

Key Statistics

Overview:

Market Capitalization, $K 82,600
Enterprise Value, $K 84,280
Shares Outstanding, K 3,087
Annual Sales, $ 0 K
Annual Net Income, $ -7,960 K
Last Quarter Sales, $ 7,410 K
Last Quarter Net Income, $ -16,240 K
EBIT, $ -21,570 K
EBITDA, $ -20,880 K
60-Month Beta 4.05
% of Insider Shareholders 12.70%
% of Institutional Shareholders 77.96%
Float, K 2,695
% Float 87.30%
Short Interest 17
Short Float 0.55%
Short Volume Ratio 0.39

Growth:

1-Year Return 321.56%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.30 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -17.08
EPS Growth vs. Prev Qtr 1.49%
EPS Growth vs. Prev Year -82.76%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/02/25

PTHS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -210.32%
Return-on-Assets % -72.82%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 4.50
Price/Cash Flow N/A
Price/Book 1.35
Book Value/Share 18.97
Interest Coverage -9.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar